| Literature DB >> 18625710 |
Anthony W Harrington1, Qi Ming Li, Chhavy Tep, Jong Bae Park, Zhigang He, Sung Ok Yoon.
Abstract
p75 and the Nogo receptor form a signaling unit for myelin inhibitory molecules, with p75 being responsible for RhoA activation. Because p75 lacks the GDP/GTP exchange factor domain, it has remained unclear how p75 activates RhoA. Here, we report that Kalirin9, a dual RhoGEF, binds p75 directly and regulates p75-Nogo receptor-dependent RhoA activation and neurite inhibition in response to myelin-associated glycoprotein. The region of p75 that Kalirin9 binds includes its mastoparan-like fifth helix, which was shown to recruit RhoGDI-RhoA. As predicted from the presence of a shared binding site, we found that Kalirin9 competes with RhoGDI for p75 binding in a dose-dependent manner in vitro. In line with these data, myelin-associated glycoprotein addition to cerebellar granule neurons resulted in a reduction in the association of Kalirin9 with p75, and a simultaneous increase in the binding of RhoGDI to p75. These results reveal a mechanism by which the fifth helix of p75 regulates RhoA activation.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18625710 PMCID: PMC2529002 DOI: 10.1074/jbc.M802188200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157